What is a stock summary page? Click here for an overview.
Business Description
Catheter Precision Inc
NAICS : 339112
SIC : 3841
ISIN : US74933X3026
Description
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.61 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | -0.18 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -16.17 | |||||
| Beneish M-Score | -3.92 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -61.2 | |||||
| 3-Year EBITDA Growth Rate | 89.2 | |||||
| 3-Year EPS without NRI Growth Rate | 86.7 | |||||
| 3-Year FCF Growth Rate | 89.9 | |||||
| 3-Year Book Growth Rate | -88.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 71.62 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 208.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.3 | |||||
| 9-Day RSI | 27.57 | |||||
| 14-Day RSI | 34.54 | |||||
| 3-1 Month Momentum % | -43.26 | |||||
| 6-1 Month Momentum % | -4.62 | |||||
| 12-1 Month Momentum % | -93.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 1.56 | |||||
| Cash Ratio | 1.38 | |||||
| Days Inventory | 408.45 | |||||
| Days Sales Outstanding | 85.51 | |||||
| Days Payable | 4818 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -730 | |||||
| Shareholder Yield % | -268.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 90 | |||||
| Operating Margin % | -2676.91 | |||||
| Net Margin % | -3962.62 | |||||
| FCF Margin % | -2223.33 | |||||
| ROE % | -105.85 | |||||
| ROA % | -59.64 | |||||
| ROIC % | -43.25 | |||||
| 3-Year ROIIC % | 83.1 | |||||
| ROC (Joel Greenblatt) % | -4961.09 | |||||
| ROCE % | -46.78 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.01 | |||||
| PB Ratio | 0.2 | |||||
| EV-to-EBIT | -0.11 | |||||
| EV-to-EBITDA | -0.14 | |||||
| EV-to-Revenue | 3.13 | |||||
| EV-to-FCF | -0.16 | |||||
| Price-to-GF-Value | 0.02 | |||||
| Earnings Yield (Greenblatt) % | -909.09 | |||||
| FCF Yield % | -388.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:VTAK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Catheter Precision Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.42 | ||
| EPS (TTM) ($) | -12.527 | ||
| Beta | -2.24 | ||
| 3-Year Sharpe Ratio | -1.12 | ||
| 3-Year Sortino Ratio | -1.48 | ||
| Volatility % | 103.84 | ||
| 14-Day RSI | 34.54 | ||
| 14-Day ATR ($) | 0.038332 | ||
| 20-Day SMA ($) | 0.368165 | ||
| 12-1 Month Momentum % | -93.68 | ||
| 52-Week Range ($) | 0.24 - 8.4 | ||
| Shares Outstanding (Mil) | 8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Catheter Precision Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Catheter Precision Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Catheter Precision Inc Frequently Asked Questions
What is Catheter Precision Inc(VTAK)'s stock price today?
The current price of VTAK is $0.30. The 52 week high of VTAK is $8.40 and 52 week low is $0.24.
When is next earnings date of Catheter Precision Inc(VTAK)?
The next earnings date of Catheter Precision Inc(VTAK) is .
Does Catheter Precision Inc(VTAK) pay dividends? If so, how much?
Catheter Precision Inc(VTAK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers